TCL Archive Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee November 16, 1979
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda February 13, 1976
